These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 1332590
21. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Entenza JM, Vouillamoz J, Glauser MP, Moreillon P. Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523 [Abstract] [Full Text] [Related]
27. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis. Scheld WM, Keeley JM. J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794 [Abstract] [Full Text] [Related]
28. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. Durack DT, Pelletier LL, Petersdorf RG. J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776 [Abstract] [Full Text] [Related]
29. beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis. Ingerman M, Pitsakis PG, Rosenberg A, Hessen MT, Abrutyn E, Murray BE, Levison ME. J Infect Dis; 1987 Jun; 155(6):1226-32. PubMed ID: 3106510 [Abstract] [Full Text] [Related]
30. Daptomycin (LY146032) treatment of experimental enterococcal endocarditis. Bush LM, Boscia JA, Kaye D. Antimicrob Agents Chemother; 1988 Jun; 32(6):877-81. PubMed ID: 2843085 [Abstract] [Full Text] [Related]
34. Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci. Anguita-Alonso P, Rouse MS, Piper KE, Steckelberg JM, Patel R. Antimicrob Agents Chemother; 2006 Apr; 50(4):1263-7. PubMed ID: 16569838 [Abstract] [Full Text] [Related]
35. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Fantin B, Leclercq R, Arthur M, Duval J, Carbon C. Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013 [Abstract] [Full Text] [Related]
36. Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis. Martínez F, Martín-Luengo F, Garcia A, Valdés M. J Antimicrob Chemother; 1994 Jun; 33(6):1201-7. PubMed ID: 7928813 [Abstract] [Full Text] [Related]
37. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin. Martínez F, Martín-Luengo F, García A, Valdés M. Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983 [Abstract] [Full Text] [Related]
38. In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis. Fantin B, Leclercq R, Ottaviani M, Vallois JM, Maziere B, Duval J, Pocidalo JJ, Carbon C. Antimicrob Agents Chemother; 1994 Mar; 38(3):432-7. PubMed ID: 8203835 [Abstract] [Full Text] [Related]
39. 3H-spiramycin penetration into fibrin vegetations in an experimental model of streptococcal endocarditis. Cremieux AC, Vallois JM, Maziere B, Ottaviani M, Bouvet A, Carbon C, Pocidalo JJ. J Antimicrob Chemother; 1988 Jul; 22 Suppl B():127-33. PubMed ID: 3182437 [Abstract] [Full Text] [Related]
40. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Cagni A, Chuard C, Vaudaux PE, Schrenzel J, Lew DP. Antimicrob Agents Chemother; 1995 Aug; 39(8):1655-60. PubMed ID: 7486895 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]